Nashville explosion: What we know about downtown explosion on Christmas morning

Prince Harry and Meghan Markle Left the Royal Family, and Took All the Drama With Them

Millions of Americans lose jobless benefits as Trump refuses to sign aid bill

I want to retire in Texas and near freshwater on $4,000 a month — where should I go?

I want to retire to Texas. Join the line of people heading to the Lone Star State — about 1,500 every day in 2018. Just a word of caution: Maine to Texas is quite a temperature switch, so consider investigating your possibilities during the summer.

Toyota announces the current-generation Land Cruiser is dead after 2021

Toyota confirmed a rumor we first caught wind of earlier in 2020 by announcing that the current-generation Land Cruiser will retire after the 2021 model year. The next-generation model will be introduced in the coming months, but we're receiving mixed signals about whether the nameplate will return to the United States. Launched in 2007 as a 2008 model, and updated twice since, the J200-generation Land Cruiser (pictured) is about to enter its 14th year on the market.

Moderna Says Coronavirus Vaccine's Effectiveness Will Likely Hold Against New SARS-CoV-2 Variants

As the world is threatened by the prospects of the SARS-CoV-2 mutating to produce new virulent strains, Moderna Inc (NASDAQ: MRNA) has reassured there isn't a cause for concern.What Happened: The vaccine-induced immunity from Moderna's coronavirus vaccine candidate - mRNA-1273 - will likely be protective against the new strain of SARS-CoV-2 recently described in the U.K., the Massachusetts-based company said in a late Wednesday statement.The company based the deduction on data to date.Testing of sera from animals and humans vaccinated with mRNA-1273 has already been done against a number of previous variants of SARS-CoV-2, and the vaccine remained equally effective.Related Link: Sarepta, Amicus Top Biotech Picks Ahead Of Key Binary Events: Analyst"The full-length Spike protein is 1,273 amino acids long, so while recent variants involve multiple mutations, for instance up to 8 amino acid changes in the spike protein of the B1.1.7 strain, these represent less than a 1% difference from the spike protein encoded by Moderna's vaccine," the company explained.What's Next: Moderna said it plans to run tests to confirm the activity of the vaccine against any strain.The broad range of potential neutralizing antibodies made possible by the mRNA-1273 provides confidence that it will also be effective at inducing neutralizing antibodies against them.Moderna's investigational vaccine candidate emergency use authorization from the FDA on Dec. 18, and most recently Health Canada has authorized it for the immunization of people 18 years of age and older under an interim order.See more from Benzinga * Click here for options trades from Benzinga * Moderna, Pfizer Testing Coronavirus Vaccine Against New Strain * The Week Ahead In Biotech: Light Calendar In Abbreviated Week Features 1 IPO, 1 FDA Decision(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Queen Elizabeth Just Broke a 33-Year Royal Christmas Tradition